サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1420148

アジア太平洋の放射性トレーサー市場の2030年までの予測-地域別分析：トレーサータイプ、検査タイプ、用途、エンドユーザー別

Asia Pacific Radioactive Tracer Market Forecast to 2030 - Regional Analysis - by Tracer Type, Test Type, Application, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 135 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
アジア太平洋の放射性トレーサー市場の2030年までの予測-地域別分析：トレーサータイプ、検査タイプ、用途、エンドユーザー別
出版日: 2023年12月04日
発行: The Insight Partners
ページ情報: 英文 135 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の放射性トレーサー市場は、2022年に16億1,580万米ドルと評価され、2030年には66億2,961万米ドルに達すると予測され、2022年から2030年までのCAGRは19.3%で成長すると予測されています。

慢性疾患の増加がアジア太平洋の放射性トレーサー市場に拍車をかける

高齢化人口の増加、社会行動の変化、座りがちなライフスタイルの増加、都市化の加速などが、肥満や糖尿病などの慢性疾患の有病率を押し上げる主な要因となっています。さらに、遺伝子が心血管疾患（CVD）、糖尿病、肥満、アルツハイマー病（AD）、うつ病などの慢性疾患を引き起こす可能性があることは、長年にわたる研究によって立証されています。

動脈硬化、狭心症、急性心筋梗塞などのCVDは、多忙なライフスタイルが原因で引き起こされ、世界的に重大な死亡原因となっています。WHOのデータによると、CVDは世界の主要死因であり、毎年1,790万人が死亡していると推定されています。糖尿病は生命を脅かす慢性疾患であり、治療法はないです。あらゆるタイプの糖尿病は、身体の様々な部位に様々な合併症を引き起こし、早死にのリスクを高める。心臓発作、脳卒中、腎不全、脚の切断、視力低下、神経損傷などは、糖尿病に伴う主な合併症のひとつです。糖尿病の有病率は、予測期間中に35％近く増加すると思われます。

したがって、慢性疾患の適切な治療には効果的な検査が必須であり、診断と検査の目的で核物質が使用されます。これらの核物質は、陽電子放射断層撮影法（PET）や単光子放射コンピュータ断層撮影法（SPECT）などの診断検査に使用され、神経疾患、心血管疾患、慢性肺疾患、慢性腎疾患などの慢性疾患を診断します。このように、慢性疾患の増加が放射性トレーサーの需要を急増させており、市場の拡大にプラスに働いています。

アジア太平洋の放射性トレーサー市場概要

アジア太平洋地域の放射性トレーサー市場は、オーストラリア、中国、インド、日本、韓国、その他アジア太平洋地域に区分されます。同地域の市場は、新たな研究施設の市場開拓、老人人口の増加、イメージング分野の技術進歩に伴うハイブリッドシステムの著しい進化などの要因により、予測期間中最も速い速度で成長し続けると思われます。

アジア太平洋地域の放射性トレーサー市場の収益と2030年までの予測（金額）

アジア太平洋地域の放射性トレーサー市場のセグメンテーション

アジア太平洋の放射性トレーサー市場は、トレーサータイプ、検査タイプ、エンドユーザー、用途、国によって区分されます。トレーサータイプ別では、アジア太平洋の放射性トレーサー市場はテクネチウム-99mとTc-97m、ヨウ素131、鉄-59、ルテチウム-171、塩化ルビジウム（Rb-82）とアンモニア（N-13）、スカンジウム-46、シーボルギウム-269、ハッシウム-269に区分される、クエン酸ガリウムGa 67、前立腺特異的膜抗原（PSMA）（Ga-68）、FDDNP（F-18）＆FDOPA（F-18）、リン-32＆クロム-51、タリウム-201、F-18 FDG、F-18 FAPI、Ga-68 FAPI、F-18 PSMA、DOTATOC/DOTANOC/DOTATATE（Ga-68）、その他。2022年には、その他セグメントが最大の市場シェアを占めました。

検査タイプ別に見ると、アジア太平洋の放射性トレーサー市場はPET、SPECT、その他に区分されます。SPECTセグメントが2022年に最大の市場シェアを占めました。

エンドユーザー別では、アジア太平洋の放射性トレーサー市場は病院＆クリニック、診断センター、学術＆研究機関、その他に区分されます。病院＆クリニックセグメントが2022年に最大の市場シェアを占めました。

用途別では、アジア太平洋の放射性トレーサー市場は、腫瘍学、肺、神経学、心臓学、その他に区分されます。2022年には腫瘍分野が最大の市場シェアを占めました。

国別では、アジア太平洋の放射性トレーサー市場は中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。2022年のアジア太平洋の放射性トレーサー市場シェアは中国が独占。

Rotem Industries Ltd、Invicro LLC、Cardinal Health Inc、Newcastle University、Novartis AG、Curium、IBA Radiopharma Solutionsは、アジア太平洋の放射性トレーサー市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の放射性トレーサー市場：主要産業力学

  • 主な市場促進要因
    • 慢性疾患の有病率の上昇
    • 核医学イメージング技術の使用の増加
  • 市場抑制要因
    • 放射性トレーサーの短い使用期限
    • 核医学画像診断手順の代替品の入手可能性
  • 市場機会
    • 新興経済国の存在と人口の増加
    • 標的治療のための個別化放射性医薬品の開発
  • 今後の動向
    • がん診断における放射性トレーサーの使用
  • 影響分析

第5章 放射性トレーサー市場：アジア太平洋市場分析

  • 放射性トレーサー市場の収益、2022年～2030年

第6章 アジア太平洋地域の放射性トレーサー市場-収益と2030年までの予測：トレーサータイプ別

  • トレーサー概要
  • 放射性トレーサー市場：2022年・2030年収益シェア（%）トレーサータイプ別
  • テクネチウム99mおよびTC-97m
  • ヨウ素131
  • 鉄59
  • ルテチウム171
  • RB82およびアンモニアN-13
  • スカンジウム46
  • シーボーギウム-269
  • ハッシウム-269
  • クエン酸ガリウムGA67
  • PSMA GA68
  • FDDNP（F-18）およびFDOPA（f-18）
  • リン32およびクロム-51
  • タリウム-201
  • F-18 FDG
  • F-18 FAPI
  • GA 68 FAPI
  • F-18 PSMA
  • DOTATOC/DOTANOC/DOTATATE GA 68
  • その他

第7章 アジア太平洋の放射性トレーサー市場-収益と2030年までの予測：検査タイプ別

  • 放射性トレーサー市場：2022年・2030年収益シェア（%）検査タイプ別
  • PET
  • SPECT
  • その他

第8章 アジア太平洋の放射性トレーサー市場：収益と2030年までの予測：用途別

  • 放射性トレーサー市場：2022年・2030年収益シェア（%）用途別
  • 腫瘍
  • 肺
  • 神経
  • 循環器
  • その他

第9章 アジア太平洋地域の放射性トレーサー市場-収益と2030年までの予測：エンドユーザー別

  • 放射性トレーサー市場：2022年・2030年収益シェア（%）エンドユーザー別
  • 病院および診療所
  • 診断センター
  • 学術・研究機関
  • その他

第10章 アジア太平洋の放射性トレーサー市場：国別分析

  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域

第11章 放射性トレーサー市場の業界情勢

  • 有機的開発
  • 無機的開発

第12章 放射性トレーサー市場：主要企業プロファイル

  • Rotem Industries Ltd
  • Invicro LLC
  • Cardinal Health Inc
  • Newcastle University
  • Novartis AG
  • Curium
  • General Electric Co
  • IBA Radiopharma Solutions

第13章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Radioactive Tracer Market Segmentation
  • Table 2. Principal Radionuclides Used in Radioactive Tracer
  • Table 3. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 4. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 5. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 6. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 7. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 8. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 9. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 10. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 11. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 12. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 13. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 14. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 15. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 16. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 17. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 18. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 19. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Type
  • Table 20. South Korea Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 21. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 22. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 23. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 24. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Test Type
  • Table 25. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 26. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 27. Organic Developments Done by Companies
  • Table 28. Inorganic Developments Done by Companies
  • Table 29. Glossary of Terms, Asia Pacific Radioactive Tracer Market

List Of Figures

  • Figure 1. Asia Pacific Radioactive Tracer Market Segmentation, By Country
  • Figure 2. Asia Pacific Radioactive Tracer Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Asia Pacific Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • Figure 6. Technetium 99m and TC-97m: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Iodine 131: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Iron 59: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Lutetium- 171: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. RB82 and ammonia N-13: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Scandium 46: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Seaborgium-269: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Hassium -269: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Gallium Citrate GA 67: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. PSMA GA68: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. FDDNP (F-18) and FDOPA (f-18): Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Phosphorus 32 and Chromium -51: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Thallium-201: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. F-18 FDG: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. F-18 FAPI: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. GA 68 FAPI: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. F-18 PSMA: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. DOTATOC/DOTANOC/DOTATATE Ga 68: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Asia Pacific Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 26. PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. SPECT: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Asia Pacific Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 30. Oncology: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pulmonary: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Neurology: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Cardiology: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Others: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Asia Pacific Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 36. Hospitals and Clinics: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Diagnostic Centers: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Academic and Research Institutes: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Others: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. Asia Pacific Radioactive Tracer Market, By Country, 2022 ($Mn)
  • Figure 41. Asia Pacific Radioactive Tracer Market, By Key Countries, 2022 And 2030 (%)
  • Figure 42. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 43. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 44. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 45. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 46. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
目次
Product Code: BMIRE00029110

The Asia Pacific radioactive tracer market was valued at US$ 1,615.80 million in 2022 and is expected to reach US$ 6,629.61 million by 2030; it is estimated to grow at a CAGR of 19.3% from 2022 to 2030.

Rising Prevalence of Chronic Diseases fuel the Asia Pacific Radioactive Tracer Market

Increasing aging population, changing social behavior, rising adoption of a sedentary lifestyle, and accelerating urbanization are the key factors boosting the prevalence of obesity and other chronic diseases such as diabetes. Further, studies have long established that genes can cause chronic conditions such as cardiovascular disease (CVD), diabetes, obesity, Alzheimer's disease (AD), and depression.

CVDs, such as atherosclerosis, angina pectoris, and acute myocardial infarction, caused due to hectic lifestyles have become significant causes of mortality worldwide. As per the data provided by the WHO, CVDs are the predominant cause of death worldwide, recording estimated 17.9 million deaths each year. Diabetes is a life-threatening chronic disease with no functional cure. Diabetes of all types can lead to various complications in different body parts and increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are among the major complications associated with diabetes. The disease prevalence will likely increase by nearly 35% during the forecast period.

Thus, an effective examination is a must for properly treating chronic diseases; hence, nuclear substances are used for diagnosis and examination purposes. These nuclear substances are used in diagnostic tests such as positron emission tomography (PET) and single-photon emission computerized tomography (SPECT) to diagnose chronic diseases such as neurological, cardiovascular, chronic lung, and chronic kidney diseases. the availability of several radiotracer across the globe makes it selection easy depending on the type of disease and its prognosis. Thus, the increasing incidences of chronic diseases are surging the demand for radioactive tracer, positively favoring market expansion.

Asia Pacific Radioactive Tracer Market Overview

The Asia Pacific radioactive tracer market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The market in the region is likely to continue to grow at the fastest rate during the forecast period owing to factors such as the development of new research facilities, the rise in the geriatric population and significant evolution of hybrid systems with technological advancement in the field of imaging.

Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Radioactive Tracer Market Segmentation

The Asia Pacific radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the Asia Pacific radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.

Based on test type, the Asia Pacific radioactive tracer market is segmented into PET, SPECT, and others. The SPECT segment held the largest market share in 2022.

Based on end user, the Asia Pacific radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.

Based on application, the Asia Pacific radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.

Based on country, the Asia Pacific radioactive tracer market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific radioactive tracer market share in 2022.

Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, and IBA Radiopharma Solutions are some of the leading players operating in the Asia Pacific radioactive tracer market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific radioactive tracer market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific radioactive tracer market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific radioactive tracer market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Radioactive Tracer Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Rising Prevalence of Chronic Diseases
    • 4.1.2 Increasing Use of Nuclear Imaging Techniques
  • 4.2 Market Restraints
    • 4.2.1 Short Shelf-Life of Radioactive Tracer
    • 4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
  • 4.3 Market Opportunities
    • 4.3.1 Presence of Emerging Economies and Growing Population
    • 4.3.2 Development of Personalized Radiopharmaceuticals for Targeted Therapies
  • 4.4 Future Trends
    • 4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
  • 4.5 Impact Analysis:

5. Radioactive Tracer Market - Asia Pacific Market Analysis

  • 5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 - by Tracer Types

  • 6.1 Overview
  • 6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • 6.3 Technetium 99m and TC-97m
    • 6.3.1 Overview
    • 6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Iodine 131
    • 6.4.1 Overview
    • 6.4.2 Iodine 131: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Iron 59
    • 6.5.1 Overview
    • 6.5.2 Iron 59: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Lutetium- 171
    • 6.6.1 Overview
    • 6.6.2 Lutetium- 171: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 RB82 and ammonia N-13
    • 6.7.1 Overview
    • 6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Scandium 46
    • 6.8.1 Overview
    • 6.8.2 Scandium 46: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.9 Seaborgium-269
    • 6.9.1 Overview
    • 6.9.2 Seaborgium-269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.10 Hassium -269
    • 6.10.1 Overview
    • 6.10.2 Hassium -269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.11 Gallium Citrate GA 67
    • 6.11.1 Overview
    • 6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.12 PSMA GA68
    • 6.12.1 Overview
    • 6.12.2 PSMA GA68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.13 FDDNP (F-18) and FDOPA (f-18)
    • 6.13.1 Overview
    • 6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.14 Phosphorus 32 and Chromium -51
    • 6.14.1 Overview
    • 6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.15 Thallium-201
    • 6.15.1 Overview
    • 6.15.2 Thallium-201: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.16 F-18 FDG
    • 6.16.1 Overview
    • 6.16.2 F-18 FDG: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.17 F-18 FAPI
    • 6.17.1 Overview
    • 6.17.2 F-18 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.18 GA 68 FAPI
    • 6.18.1 Overview
    • 6.18.2 GA 68 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.19 F-18 PSMA
    • 6.19.1 Overview
    • 6.19.2 F-18 PSMA: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.20 DOTATOC/DOTANOC/DOTATATE Ga 68
    • 6.20.1 Overview
    • 6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.21 Others
    • 6.21.1 Overview
    • 6.21.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 PET
    • 7.3.1 Overview
    • 7.3.2 PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 SPECT
    • 7.4.1 Overview
    • 7.4.2 SPECT: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 - by Application.

  • 8.1 Overview
  • 8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Oncology
    • 8.3.1 Overview
    • 8.3.2 Oncology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Pulmonary
    • 8.4.1 Overview
    • 8.4.2 Pulmonary: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Neurology
    • 8.5.1 Overview
    • 8.5.2 Neurology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cardiology
    • 8.6.1 Overview
    • 8.6.2 Cardiology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Centers: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Radioactive Tracer Market - Country Analysis

  • 10.1 Asia Pacific Radioactive Tracer Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific Radioactive Tracer Market by Country
      • 10.1.2.1 China
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.3 China Radioactive Tracer Market, by Tracer Types
        • 10.1.2.1.4 China Radioactive Tracer Market, by Test Type
        • 10.1.2.1.5 China Radioactive Tracer Market, by Application
        • 10.1.2.1.6 China Radioactive Tracer Market, by End-User
      • 10.1.2.2 Japan
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Japan Radioactive Tracer Market, by Tracer Types
        • 10.1.2.2.4 Japan Radioactive Tracer Market, by Test Type
        • 10.1.2.2.5 Japan Radioactive Tracer Market, by Application
        • 10.1.2.2.6 Japan Radioactive Tracer Market, by End-User
      • 10.1.2.3 India
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 India Radioactive Tracer Market, by Tracer Types
        • 10.1.2.3.4 India Radioactive Tracer Market, by Test Type
        • 10.1.2.3.5 India Radioactive Tracer Market, by Application
        • 10.1.2.3.6 India Radioactive Tracer Market, by End-User
      • 10.1.2.4 Australia
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Australia Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.3 Australia Radioactive Tracer Market, by Tracer Types
        • 10.1.2.4.4 Australia Radioactive Tracer Market, by Test Type
        • 10.1.2.4.5 Australia Radioactive Tracer Market, by Application
        • 10.1.2.4.6 Australia Radioactive Tracer Market, by End-User
      • 10.1.2.5 South Korea
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.3 South Korea Radioactive Tracer Market, by Tracer Type
        • 10.1.2.5.4 South Korea Radioactive Tracer Market, by Test Type
        • 10.1.2.5.5 South Korea Radioactive Tracer Market, by Application
        • 10.1.2.5.6 South Korea Radioactive Tracer Market, by End-User
      • 10.1.2.6 Rest of Asia Pacific
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.3 Rest of Asia Pacific Radioactive Tracer Market, by Tracer Types
        • 10.1.2.6.4 Rest of Asia Pacific Radioactive Tracer Market, by Test Type
        • 10.1.2.6.5 Rest of Asia Pacific Radioactive Tracer Market, by Application
        • 10.1.2.6.6 Rest of Asia Pacific Radioactive Tracer Market, by End-User

11. Radioactive Tracer Market Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Radioactive Tracer Market, Key Company Profiles

  • 12.1 Rotem Industries Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Invicro LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Cardinal Health Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Newcastle University
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Novartis AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Curium
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 General Electric Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 IBA Radiopharma Solutions
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms